NCT05872191

Brief Summary

The purpose of this cross-sectional study is to translate and cross-culturally adapt to Spanish the Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES) and the Stroke Upper Limb Capacity Scale (SULCS) and to assess their psychometric properties in Spanish people with chronic stroke.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 24, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 24, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
Last Updated

December 11, 2024

Status Verified

May 1, 2024

Enrollment Period

2.1 years

First QC Date

March 24, 2023

Last Update Submit

December 5, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change of functional impairment of the hemiparetic upper extremity: Motor Evaluation Scale for Upper Extremity in Stroke Patients (MESUPES).

    The MESUPES assesses the quality of movement performance of the hemiparetic arm and hand in people with stroke. It is a 17-item scale divided into two subscales: one for arm function (8 items with 6 response categories (0-5)) and other for hand function ("range of motion" 6 items; and "orientation during functional tasks" 3 items, with 3 response categories (0-2)). The maximum achievable score is 58 (MESUPES-Arm maximum score is 40; MESUPES-Hand maximum score is 18), with higher scores indicating better function

    Change from baseline to re-test

  • Change of functional impairment of the hemiparetic upper extremity: Stroke Upper Limb Capacity Scale (SULCS)

    The SULCS is a 10-item scale in which the ability to perform daily activities with the hemiparetic upper limb in increasing difficulty is assessed. The scoring is dichotomous (0, unable to perform the task; 1, able to perform the task). This results in a sum score ranging from 0 to 10 with higher scores indicating better functional capacity.

    Change from baseline to re-test

Secondary Outcomes (10)

  • Cognitive function: Montreal Cognitive Assessment (MoCA)

    The cohort group will be assessed at baseline

  • Disability: Modified Rankin Scale (mRS)

    The cohort group will be assessed at baseline

  • Stroke impact: Stroke Impact Scale v 3.0. (SIS)

    The cohort group will be assessed at baseline

  • Muscle spasticity: Modified Ashworth Scale (MAS)

    The cohort group will be assessed at baseline

  • Motor function: Fugl-Meyer Assessment- Upper Limb (FMA-UE)

    The cohort group will be assessed at baseline

  • +5 more secondary outcomes

Study Arms (1)

Upper extremity functional impairment due to chronic stroke

Spanish-native speakers with functional impairment of the upper extremity after stroke in chronic phase.

Other: No intervention

Interventions

There is no intervention to be administered, only collection of data through various tests and questionnaires.

Upper extremity functional impairment due to chronic stroke

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Spanish-native speakers with functional impairment of the upper extremity after stroke in chronic phase.

You may qualify if:

  • Spanish-native speakers aged between 18 and 80 years with:
  • Functional impairment of the upper extremity due to hemiparesis secondary to a stroke of ≥6 months of evolution
  • Clinical stability
  • Sufficient cognitive capacity to give consent to participate in the study and to understand and perform the assessment tests

You may not qualify if:

  • Bilateral motor impairment
  • Neurological impairment other than stroke (both central and peripheral nervous systems), musculoskeletal impairment (amputation, fracture, etc.) or disabling pain (Visual Analogue Scale score \> 5) that may affect the performance of the tests

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Valencia

Valencia, Valencia, 46010, Spain

Location

Study Officials

  • Maria-Arantzazu Ruescas-Nicolau, PT, PhD

    Department of Physiotherapy, University of Valencia (Spain)

    PRINCIPAL INVESTIGATOR
  • M.Luz Sánchez-Sánchez, PT, PhD

    Department of Physiotherapy, University of Valencia (Spain)

    PRINCIPAL INVESTIGATOR
  • Lirios Dueñas, PT, PhD

    Department of Physiotherapy, University of Valencia (Spain)

    STUDY DIRECTOR
  • Monja Spotti, PT, MSc

    Faculty of Physiotherapy, University of Valencia (Spain)

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Physiotherapy

Study Record Dates

First Submitted

March 24, 2023

First Posted

May 24, 2023

Study Start

December 1, 2023

Primary Completion

January 1, 2026

Study Completion

June 1, 2026

Last Updated

December 11, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations